Sign inGet started

Connaughton Bernadette

Insider CIK 1662521 · HALO Director · SYNH Director · EDIT Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
HALO HALOZYME THERAPEUTICS, INC S Sale2026-08-102026-08-111,626$102.80 $167.2K40,418SEC↗
HALO HALOZYME THERAPEUTICS, INC S Sale2026-08-102026-08-111,626$102.80 $167.2K40,418SEC↗
HALO HALOZYME THERAPEUTICS, INC S Sale2026-07-012026-07-021,000$76.40 $76.4K42,669SEC↗
HALO HALOZYME THERAPEUTICS, INC S Sale2026-07-012026-07-02625$77.21 $48.3K42,044SEC↗
EDIT Editas Medicine, Inc. A Award deriv2026-06-172026-06-2251,700— $051,700SEC↗
HALO HALOZYME THERAPEUTICS, INC S Sale2026-06-012026-06-021,625$66.21 $107.6K43,669SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award deriv2026-05-052026-05-076,040— $06,040SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award2026-05-052026-05-076,796— $045,294SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award2026-05-052026-10-083,796— $042,294SEC↗
HALO HALOZYME THERAPEUTICS, INC S Sale2026-05-012026-05-051,625$63.48 $103.2K38,498SEC↗
HALO HALOZYME THERAPEUTICS, INC S Sale2026-01-052026-01-062,000$70.25 $140.5K40,123SEC↗
HALO HALOZYME THERAPEUTICS, INC S Sale2025-12-012025-12-01829$71.60 $59.4K42,123SEC↗
HALO HALOZYME THERAPEUTICS, INC S Sale2025-11-102025-11-122,000$68.48 $137.0K42,952SEC↗
HALO HALOZYME THERAPEUTICS, INC S Sale2025-10-012025-10-011,500$75.09 $112.6K45,452SEC↗
HALO HALOZYME THERAPEUTICS, INC S Sale2025-10-012025-10-01500$75.70 $37.9K44,952SEC↗
HALO HALOZYME THERAPEUTICS, INC S Sale2025-09-022025-09-02100$71.71 $7.2K50,852SEC↗
HALO HALOZYME THERAPEUTICS, INC S Sale2025-09-022025-09-02923$74.11 $68.4K46,952SEC↗
HALO HALOZYME THERAPEUTICS, INC S Sale2025-09-022025-09-022,977$73.62 $219.2K47,875SEC↗
EDIT Editas Medicine, Inc. A Award deriv2025-06-062025-06-1037,500— $037,500SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award deriv2025-05-012025-05-025,750— $05,750SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award2025-05-012025-05-024,165— $050,952SEC↗
EDIT Editas Medicine, Inc. A Award deriv2024-05-302024-06-0325,000— $025,000SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award deriv2024-04-252024-04-298,804— $08,804SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award2024-04-252024-04-296,501— $046,787SEC↗
SYNH Syneos Health, Inc. D To issuer2023-09-282023-09-284,863— $00SEC↗
SYNH Syneos Health, Inc. D To issuer2023-09-282023-09-289,915$43.00 $426.3K4,863SEC↗
EDIT Editas Medicine, Inc. A Award deriv2023-06-012023-06-0525,000— $025,000SEC↗
SYNH Syneos Health, Inc. A Award2023-05-252023-05-304,863— $014,778SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award deriv2023-05-052023-05-0911,371— $011,371SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award2023-05-052023-05-098,065— $040,286SEC↗
HALO HALOZYME THERAPEUTICS, INC G Gift2022-11-162022-11-175,998— $032,221SEC↗
EDIT Editas Medicine, Inc. A Award deriv2022-06-092022-06-1325,000— $025,000SEC↗
SYNH Syneos Health, Inc. A Award2022-05-252022-05-272,839— $09,915SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award2022-05-052022-05-066,206— $038,219SEC↗
EDIT Editas Medicine, Inc. A Award deriv2021-10-262021-10-2824,732— $024,732SEC↗
SYNH Syneos Health, Inc. A Award2021-05-122021-05-142,364— $07,076SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award2021-05-052021-05-065,230— $032,013SEC↗
SYNH Syneos Health, Inc. A Award2020-05-272020-05-292,803$62.43 $175.0K4,712SEC↗
HALO HALOZYME THERAPEUTICS, INC A Award2020-04-302020-05-018,829— $026,783SEC↗
SYNH Syneos Health, Inc. A Award2019-11-122019-11-141,909$49.48 $94.5K1,909SEC↗
HALO HALOZYME THERAPEUTICS INC A Award2019-05-022019-05-0312,173— $017,954SEC↗
HALO HALOZYME THERAPEUTICS INC A Award2018-09-072018-09-115,781— $05,781SEC↗